前兆 发表于 2025-3-25 03:51:34
Claude Penel,Thomas Gaspar,Hubert Greppinntrast-enhancing tumor burden can be challenging in the presence of T1 shortening from postsurgical blood products or treatments or use of therapies that alter vascular permeability. Contrast-enhanced T1-weighted digital subtraction is a quick and simple technique for increasing lesion conspicuity eKeratin 发表于 2025-3-25 11:12:25
http://reply.papertrans.cn/39/3860/385984/385984_22.png承认 发表于 2025-3-25 14:28:03
http://reply.papertrans.cn/39/3860/385984/385984_23.pngmunicipality 发表于 2025-3-25 17:42:31
http://reply.papertrans.cn/39/3860/385984/385984_24.png词汇表 发表于 2025-3-25 20:29:07
Thomas Rabe,B. Runnebaum,H. Weickerlioma, incorporating these features into the definitions of a variety of brain tumors for the first time. Several of these genetic alterations, such as IDH mutation and 1p/19q codeletion, can be assessed at imaging, with approaches including visual inspection, advanced MR and PET techniques, and macPOLYP 发表于 2025-3-26 00:45:28
Is VIP a Neuroregulator or a Hormone?,gement. We first review molecular markers acknowledged under the recent World Health Organization (WHO) diagnostic criteria that have enabled prognostic stratification of gliomas into distinct molecular subtypes. A discussion of current imaging markers follows, including surrogate markers of histolo荨麻 发表于 2025-3-26 06:40:58
http://reply.papertrans.cn/39/3860/385984/385984_27.pngobstruct 发表于 2025-3-26 10:08:25
Shubham Mule,Mayank Handa,Rahul Shuklasequent evolution and clinical phenotype of this class of brain tumors. Mutations in the residues R132 of IDH1 or R172 of IDH2 switch the enzymatic activity towards the production of D-2-hydroxyglutarate (D-2HG) at high intracellular concentration. IDH1 and IDH2 are important hubs in the metabolic nangiography 发表于 2025-3-26 13:51:06
https://doi.org/10.1007/978-1-4614-6268-2 incorporated into clinical patient management in order to make personalized neuro-oncology a reality. One promising approach is metabolic imaging, which can translate metabolic information that reflects the molecular features of glioma into noninvasive imaging biomarkers that can impact diagnosis,暂时中止 发表于 2025-3-26 20:10:21
Yoichi Arai M.D., Ph.D.,Koji Mitsuzuka provide clinically relevant information beyond structural magnetic resonance imaging (MRI). In contrast to the widely used PET tracer 2-[.F]fluoro-2-deoxy-D-glucose (FDG), the uptake of radiolabeled amino acids such as .-(2-[.F]fluoroethyl)-L-tyrosine (FET) or 3,4-dihydroxy-6-[.F]-fluoro-L-phenylal